Back to Results
First PageMeta Content
Pharmaceuticals policy / Research / Clinical research / Food and Drug Administration / Generic drug / Drug Price Competition and Patent Term Restoration Act / Abbreviated New Drug Application / New Drug Application / Repaglinide / Pharmaceutical sciences / Pharmaceutical industry / Pharmacology


[removed]Caraco Pharmaceutical Laboratories, LTD. v. Novo Nordisk A/S[removed])
Add to Reading List

Document Date: 2012-04-17 08:23:53

Open Document

File Size: 175,39 KB

Share Result on Facebook

City

Washington / D. C. / /

Company

NOVO NORDISK A/S ET / CARACO PHARMACEUTICAL LABORATORIES LTD. / Orange Book / unsur- 4 CARACO PHARMACEUTICAL LABORATORIES LTD. / Medtronic Inc. / Apotex Inc. / Detroit Timber & Lumber Co. / CFR 2 CARACO PHARMACEUTICAL LABORATORIES LTD. / See Eli Lilly & Co. / Syllabus CARACO PHARMACEUTICAL LABORATORIES LTD. / Eli Lilly & Co. / CARACO PHARMACEUTICAL LABORATORIES LTD. ET / Mylan Pharmaceuticals Inc. / NOVO NORDISK A/S / /

Country

United States / /

Event

Second Stock Issuance / FDA Phase / Patent Filing / /

Facility

SUPREME COURT OF THE / /

IndustryTerm

brand manufacturer / generic manufacturer / brand-name product / proper applications / /

MedicalCondition

diabetes / /

Organization

Food and Drug Administration / CA Fed / District Court / Supreme Court / Federal Trade Commission / SUPREME COURT OF THE UNITED STATES / Congress / UN Court / US Federal Reserve / SUPREME COURT OF THE UNITED STATES Syllabus CARACO PHARMACEUTICAL LABORATORIES / /

Position

Reporter / /

Product

repaglinide / such drug / Approved Drug / generic drug / /

SocialTag